That is pretty close to where it should be prior to FDA approval...A slow and even rise to that level over the next two weeks would be preferred but unlikely. Simply put, no rise until the FDA PR and then...ka-booom!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.